台湾达伯耐 超过20万名普通患者免费用药，药物捐赠总价值超36亿元人民币。 信达生物始终致力于为患者提供可负担, 且更为优质的治疗选择，深受患者信任 ...

Double-tap to zoom
{"mobile_buybox_group_1":[{"displayPrice":"452","priceAmount":452,"currencySymbol":"฿","integerValue":"53","decimalSeparator":".","fractionalValue":"37","symbolPosition":"left","hasSpace":false,"showFractionalPartIfEmpty":true,"offerListingId":"hMgo7uS1E%2FhUs32TFWNveFKWEdaJk38Dw3aCNRV4dCK7sn5YsVqEmDV9ZHJNXHt8o5eJQwP80VhkEO%2Bs%2Beaav94j50zTgO9NHl1Mb2pipVrq67wnRhV%2Bvr9rPKC5CYeZZPhq1EoDWvs4OmWjqr0CMAyeNtu47Cjf6cBbY9m67oakHSYJ058rnw%3D%3D","locale":"en-US","buyingOptionType":"NEW","aapiBuyingOptionIndex":0}]}
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.

Purchase options and add-ons

452
FREE Shipping to Thailand Details

Shipping & Fee Details

Price 452
AmazonGlobal Shipping $0.00
Estimated Import Fees Deposit
Total $3,054.88

Sales taxes may apply at checkout
達伯坦的建議劑量為13 5 毫克 每日口服一次 連續服用14 天 接著停藥7 天 整個週期 為期21 天 請繼續接受治療 直到疾病惡化或出現無法接受的毒性 達伯坦可與或不與食物  22 ส ค 2567 达伯特是中国首个获批的KRAS G12C抑制剂 它的获批填补了40年国内KRAS G12C突变靶向治疗的空白 为患者带来了精准治疗的全新选择 肺癌是中国第一大恶性  達伯坦的建議劑量為13 5 毫克 每日口服一次 連續服用14 天 接著停藥7 天 整個週期 為期21 天 請繼續接受治療 直到疾病惡化或出現無法接受的毒性 達伯坦可與或不與食物  达伯舒 信迪利单抗注射液 IBI 308 一种创新全人源PD 1单克隆抗体 用于治疗 该药由Incyte和信达生物共同开发 信达生物负责该药品在中国大陆 香港 澳门和台湾地区的商业  超过20万名普通患者免费用药 药物捐赠总价值超36亿元人民币 信达生物始终致力于为患者提供可负担 且更为优质的治疗选择 深受患者信任 

• ตารางแข่งทีมคลับ บรูกก์ • Goat432AutoBet • skslot • ทอง0.6กรัมราคาวันนี้ • uw99slotth • • 台灣達伯耐企業股份有限公司 - 1111商搜網 • 台灣達伯耐企業股份有限公司 • 達伯坦錠4.5 毫克 • 达伯坦®在中国澳门获批上市，成为澳门首个获批治疗胆管癌 ... • 信达生物- 维基百科，自由的百科全书 • 博瑞達應用材料股份有限公司| 橡膠| 塑料| 彈性體 • 信达生物FGFR小分子抑制剂达伯坦®（pemigatinib）在台湾 ... • 填补中国40年靶向治疗空白达伯特（氟泽雷塞片）治疗KRAS ... • 信达生物宣布达伯坦在台湾市场获得批准用于治疗成人接受 ... • 信达生物制药集团2025年度期中业绩报告

In Stock
฿452 () Includes selected options. Includes initial monthly payment and selected options. Details
Price
Subtotal
$$53
Subtotal
Initial payment breakdown
Shipping cost, delivery date, and order total (including tax) shown at checkout.
Add To Cart
Buy Now
Ships from
Amazon
Amazon
Ships from
Amazon
Returns
30-day refund/replacement
30-day refund/replacement
This item can be returned in its original condition for a full refund or replacement within 30 days of receipt.
Read full return policy
Support
Product support included
What's Product Support?
In the event your product doesn't work as expected or you need help using it, Amazon offers free product support options such as live phone/chat with an Amazon associate, manufacturer contact information, step-by-step troubleshooting guides, and help videos. By solving product issues, we help the planet by extending the life of products. Availability of support options differ by product and country.
Payment
Secure transaction
Your transaction is secure
We work hard to protect your security and privacy. Our payment security system encrypts your information during transmission. We don’t share your credit card details with third-party sellers, and we don’t sell your information to others.
Item couldn't be saved. Please try again later. This item could not be removed from your list. Please try again later
{"mobile_buybox_group_1":[{"displayPrice":"$53","priceAmount":53,"currencySymbol":"$","integerValue":"53","decimalSeparator":".","fractionalValue":"37","symbolPosition":"left","hasSpace":false,"showFractionalPartIfEmpty":true,"offerListingId":"hMgo7uS1E%2FhUs32TFWNveFKWEdaJk38Dw3aCNRV4dCK7sn5YsVqEmDV9ZHJNXHt8o5eJQwP80VhkEO%2Bs%2Beaav94j50zTgO9NHl1Mb2pipVrq67wnRhV%2Bvr9rPKC5CYeZZPhq1EoDWvs4OmWjqr0CMAyeNtu47Cjf6cBbY9m67oakHSYJ058rnw%3D%3D","locale":"en-US","buyingOptionType":"NEW","aapiBuyingOptionIndex":0}]}
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.
Loading recommendations for you
Continue Shopping

Added to Cart

Not Added

Item is in your Cart

Not Added

There was a problem adding this item to Cart. Please try again later.
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.

Customer reviews

4.9 out of 5 stars
525753 global ratings

Top reviews from the Thailand

  • lucky_7470
    5.0 out of 5 starsVerified Purchase
    达伯坦®在中国澳门获批上市，成为澳门首个获批治疗胆管癌 ...
    Reviewed in the Thailand on July 6, 2025
    台灣達伯耐企業股份有限公司. 聯絡人：李小姐電話：(06)7945113 傳真：(06)7945820 地址：台南市將軍區北埔村111號. 公司簡介. 本公司至民國八十一年成立至今以十三餘年， ...
    Helpful
    Share

    Report this review

    Optional: Why are you reporting this?

    Not about the product

    Disrespectful, hateful, obscene

    Paid for, inauthentic

    Something else

    We’ll check if this review meets our community guidelines. If it doesn’t, we’ll remove it.

    Submit
    Report
  • winner_8950
    1.0 out of 5 starsVerified Purchase
    達伯坦錠4.5 毫克
    Reviewed in the Thailand on July 17, 2025
    达伯坦®（由Incyte和信达生物共同开发，信达生物负责中国大陆、香港、澳门和台湾地区的商业化）是首个在台湾市场获批的治疗胆道恶性肿瘤的酪氨酸激酶抑制剂。这是信达生物获批 ...
    One person found this helpful
    Helpful
    Share

    Report this review

    Optional: Why are you reporting this?

    Not about the product

    Disrespectful, hateful, obscene

    Paid for, inauthentic

    Something else

    We’ll check if this review meets our community guidelines. If it doesn’t, we’ll remove it.

    Submit
    Report
  • user9889
    1.0 out of 5 stars
    信达生物FGFR小分子抑制剂达伯坦®（pemigatinib）在台湾 ...
    Reviewed in the Thailand on June 25, 2025
    达伯坦®（由Incyte和信达生物共同开发，信达生物负责中国大陆、香港、澳门和台湾地区的商业化）是首个在台湾市场获批的治疗胆道恶性肿瘤的酪氨酸激酶抑制剂。这是信达生物获批 ...
    15 people found this helpful
    Helpful
    Share

    Report this review

    Optional: Why are you reporting this?

    Not about the product

    Disrespectful, hateful, obscene

    Paid for, inauthentic

    Something else

    We’ll check if this review meets our community guidelines. If it doesn’t, we’ll remove it.

    Submit
    Report